Investors > Corporate Governance
Corporate Documents
NASDAQ: OKYO
Annual reports
Interim Reports
Corporate Documents
Registration Statement for former UK shareholders effective
Memorandum and Articles of Association Amended May 2023
Result of General Meeting 3.5.23
OKYO Pharma GM Proxy Form GM v.2
Notice of Intention To Delist From The London Stock Exchange
Memorandum and Articles of Incorporation
Notice of Annual General Meeting 2020
Notice of Annual General Meeting 2018
Admission Prospectus to OKYO Pharma Ltd.
Cancellation of AIM Listing and Migration Circular
Memorandum of Association Articles of Association
Proposed Disposal and Special Dividend, Change of Name and Notice of General Meeting